(1)
Dr. Anil Kumar Muthineni. Efficacy And Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: A Phase Iii Randomized, Double-Blind, Placebo-Controlled Trial. JRTDD 2022, 5, 776-781.